questionsmedicales.fr
Lipides
Lipides membranaires
Sphingolipides
Sphingolipides : Questions médicales fréquentes
Termes MeSH sélectionnés :
Microbial Sensitivity Tests
Diagnostic
5
Maladies métaboliques
Sphingolipides
Analyse sanguine
Sphingolipides
Symptômes neurologiques
Sphingolipides
Imagerie par résonance magnétique
Sphingolipides
Antécédents familiaux
Sphingolipides
Symptômes
5
Symptômes neurologiques
Sphingolipides
Troubles digestifs
Sphingolipides
Système nerveux
Sphingolipides
Affections cutanées
Sphingolipides
Types de sphingolipides
Sphingolipides
Prévention
5
Prévention des maladies
Sphingolipides
Tests génétiques
Sphingolipides
Éducation à la santé
Sphingolipides
Habitudes alimentaires
Sphingolipides
Vaccination
Sphingolipides
Traitements
5
Thérapie enzymatique
Sphingolipides
Régime alimentaire
Sphingolipides
Médicaments
Sphingolipides
Essais cliniques
Sphingolipides
Thérapie génique
Sphingolipides
Complications
5
Complications
Sphingolipides
Troubles respiratoires
Sphingolipides
Maladies cardiovasculaires
Sphingolipides
Complications neurologiques
Sphingolipides
Réversibilité
Sphingolipides
Facteurs de risque
5
Facteurs de risque
Sphingolipides
Maladies auto-immunes
Sphingolipides
Mode de vie
Sphingolipides
Infections
Sphingolipides
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Sphingolipides : Questions médicales les plus fréquentes",
"headline": "Sphingolipides : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Sphingolipides : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-13",
"dateModified": "2025-03-10",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Sphingolipides"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Lipides membranaires",
"url": "https://questionsmedicales.fr/mesh/D008563",
"about": {
"@type": "MedicalCondition",
"name": "Lipides membranaires",
"code": {
"@type": "MedicalCode",
"code": "D008563",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Glycosphingolipides",
"alternateName": "Glycosphingolipids",
"url": "https://questionsmedicales.fr/mesh/D006028",
"about": {
"@type": "MedicalCondition",
"name": "Glycosphingolipides",
"code": {
"@type": "MedicalCode",
"code": "D006028",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Glycosphingolipides acides",
"alternateName": "Acidic Glycosphingolipids",
"url": "https://questionsmedicales.fr/mesh/D020384",
"about": {
"@type": "MedicalCondition",
"name": "Glycosphingolipides acides",
"code": {
"@type": "MedicalCode",
"code": "D020384",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Gangliosides",
"alternateName": "Gangliosides",
"url": "https://questionsmedicales.fr/mesh/D005732",
"about": {
"@type": "MedicalCondition",
"name": "Gangliosides",
"code": {
"@type": "MedicalCode",
"code": "D005732",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.475"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Ganglioside GM1",
"alternateName": "G(M1) Ganglioside",
"url": "https://questionsmedicales.fr/mesh/D005677",
"about": {
"@type": "MedicalCondition",
"name": "Ganglioside GM1",
"code": {
"@type": "MedicalCode",
"code": "D005677",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.475.390"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ganglioside GM2",
"alternateName": "G(M2) Ganglioside",
"url": "https://questionsmedicales.fr/mesh/D005678",
"about": {
"@type": "MedicalCondition",
"name": "Ganglioside GM2",
"code": {
"@type": "MedicalCode",
"code": "D005678",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.475.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ganglioside GM3",
"alternateName": "G(M3) Ganglioside",
"url": "https://questionsmedicales.fr/mesh/D005679",
"about": {
"@type": "MedicalCondition",
"name": "Ganglioside GM3",
"code": {
"@type": "MedicalCode",
"code": "D005679",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.475.510"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Ganglioside GM1",
"alternateName": "G(M1) Ganglioside",
"url": "https://questionsmedicales.fr/mesh/D005677",
"about": {
"@type": "MedicalCondition",
"name": "Ganglioside GM1",
"code": {
"@type": "MedicalCode",
"code": "D005677",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.475.390"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ganglioside GM2",
"alternateName": "G(M2) Ganglioside",
"url": "https://questionsmedicales.fr/mesh/D005678",
"about": {
"@type": "MedicalCondition",
"name": "Ganglioside GM2",
"code": {
"@type": "MedicalCode",
"code": "D005678",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.475.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ganglioside GM3",
"alternateName": "G(M3) Ganglioside",
"url": "https://questionsmedicales.fr/mesh/D005679",
"about": {
"@type": "MedicalCondition",
"name": "Ganglioside GM3",
"code": {
"@type": "MedicalCode",
"code": "D005679",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.475.510"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfoglycosphingolipides",
"alternateName": "Sulfoglycosphingolipids",
"url": "https://questionsmedicales.fr/mesh/D013433",
"about": {
"@type": "MedicalCondition",
"name": "Sulfoglycosphingolipides",
"code": {
"@type": "MedicalCode",
"code": "D013433",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.837"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Gangliosides",
"alternateName": "Gangliosides",
"url": "https://questionsmedicales.fr/mesh/D005732",
"about": {
"@type": "MedicalCondition",
"name": "Gangliosides",
"code": {
"@type": "MedicalCode",
"code": "D005732",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.475"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Ganglioside GM1",
"alternateName": "G(M1) Ganglioside",
"url": "https://questionsmedicales.fr/mesh/D005677",
"about": {
"@type": "MedicalCondition",
"name": "Ganglioside GM1",
"code": {
"@type": "MedicalCode",
"code": "D005677",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.475.390"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ganglioside GM2",
"alternateName": "G(M2) Ganglioside",
"url": "https://questionsmedicales.fr/mesh/D005678",
"about": {
"@type": "MedicalCondition",
"name": "Ganglioside GM2",
"code": {
"@type": "MedicalCode",
"code": "D005678",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.475.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ganglioside GM3",
"alternateName": "G(M3) Ganglioside",
"url": "https://questionsmedicales.fr/mesh/D005679",
"about": {
"@type": "MedicalCondition",
"name": "Ganglioside GM3",
"code": {
"@type": "MedicalCode",
"code": "D005679",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.475.510"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Ganglioside GM1",
"alternateName": "G(M1) Ganglioside",
"url": "https://questionsmedicales.fr/mesh/D005677",
"about": {
"@type": "MedicalCondition",
"name": "Ganglioside GM1",
"code": {
"@type": "MedicalCode",
"code": "D005677",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.475.390"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ganglioside GM2",
"alternateName": "G(M2) Ganglioside",
"url": "https://questionsmedicales.fr/mesh/D005678",
"about": {
"@type": "MedicalCondition",
"name": "Ganglioside GM2",
"code": {
"@type": "MedicalCode",
"code": "D005678",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.475.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ganglioside GM3",
"alternateName": "G(M3) Ganglioside",
"url": "https://questionsmedicales.fr/mesh/D005679",
"about": {
"@type": "MedicalCondition",
"name": "Ganglioside GM3",
"code": {
"@type": "MedicalCode",
"code": "D005679",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.475.510"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfoglycosphingolipides",
"alternateName": "Sulfoglycosphingolipids",
"url": "https://questionsmedicales.fr/mesh/D013433",
"about": {
"@type": "MedicalCondition",
"name": "Sulfoglycosphingolipides",
"code": {
"@type": "MedicalCode",
"code": "D013433",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.025.837"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glycosphingolipides neutres",
"alternateName": "Neutral Glycosphingolipids",
"url": "https://questionsmedicales.fr/mesh/D020383",
"about": {
"@type": "MedicalCondition",
"name": "Glycosphingolipides neutres",
"code": {
"@type": "MedicalCode",
"code": "D020383",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Céramides",
"alternateName": "Ceramides",
"url": "https://questionsmedicales.fr/mesh/D002518",
"about": {
"@type": "MedicalCondition",
"name": "Céramides",
"code": {
"@type": "MedicalCode",
"code": "D002518",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cérébrosides",
"alternateName": "Cerebrosides",
"url": "https://questionsmedicales.fr/mesh/D002554",
"about": {
"@type": "MedicalCondition",
"name": "Cérébrosides",
"code": {
"@type": "MedicalCode",
"code": "D002554",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Galactosylcéramides",
"alternateName": "Galactosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005699",
"about": {
"@type": "MedicalCondition",
"name": "Galactosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005699",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glucosylcéramides",
"alternateName": "Glucosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005963",
"about": {
"@type": "MedicalCondition",
"name": "Glucosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005963",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.490"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Galactosylcéramides",
"alternateName": "Galactosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005699",
"about": {
"@type": "MedicalCondition",
"name": "Galactosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005699",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glucosylcéramides",
"alternateName": "Glucosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005963",
"about": {
"@type": "MedicalCondition",
"name": "Glucosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005963",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.490"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Globosides",
"alternateName": "Globosides",
"url": "https://questionsmedicales.fr/mesh/D005915",
"about": {
"@type": "MedicalCondition",
"name": "Globosides",
"code": {
"@type": "MedicalCode",
"code": "D005915",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.425"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lactosylcéramides",
"alternateName": "Lactosylceramides",
"url": "https://questionsmedicales.fr/mesh/D007790",
"about": {
"@type": "MedicalCondition",
"name": "Lactosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D007790",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.612"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Trihexosylcéramide",
"alternateName": "Trihexosylceramides",
"url": "https://questionsmedicales.fr/mesh/D014281",
"about": {
"@type": "MedicalCondition",
"name": "Trihexosylcéramide",
"code": {
"@type": "MedicalCode",
"code": "D014281",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.906"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Cérébrosides",
"alternateName": "Cerebrosides",
"url": "https://questionsmedicales.fr/mesh/D002554",
"about": {
"@type": "MedicalCondition",
"name": "Cérébrosides",
"code": {
"@type": "MedicalCode",
"code": "D002554",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Galactosylcéramides",
"alternateName": "Galactosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005699",
"about": {
"@type": "MedicalCondition",
"name": "Galactosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005699",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glucosylcéramides",
"alternateName": "Glucosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005963",
"about": {
"@type": "MedicalCondition",
"name": "Glucosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005963",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.490"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Galactosylcéramides",
"alternateName": "Galactosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005699",
"about": {
"@type": "MedicalCondition",
"name": "Galactosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005699",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glucosylcéramides",
"alternateName": "Glucosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005963",
"about": {
"@type": "MedicalCondition",
"name": "Glucosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005963",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.490"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Globosides",
"alternateName": "Globosides",
"url": "https://questionsmedicales.fr/mesh/D005915",
"about": {
"@type": "MedicalCondition",
"name": "Globosides",
"code": {
"@type": "MedicalCode",
"code": "D005915",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.425"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lactosylcéramides",
"alternateName": "Lactosylceramides",
"url": "https://questionsmedicales.fr/mesh/D007790",
"about": {
"@type": "MedicalCondition",
"name": "Lactosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D007790",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.612"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Trihexosylcéramide",
"alternateName": "Trihexosylceramides",
"url": "https://questionsmedicales.fr/mesh/D014281",
"about": {
"@type": "MedicalCondition",
"name": "Trihexosylcéramide",
"code": {
"@type": "MedicalCode",
"code": "D014281",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.906"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sphingomyéline",
"alternateName": "Sphingomyelins",
"url": "https://questionsmedicales.fr/mesh/D013109",
"about": {
"@type": "MedicalCondition",
"name": "Sphingomyéline",
"code": {
"@type": "MedicalCode",
"code": "D013109",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.870"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Céramides",
"alternateName": "Ceramides",
"url": "https://questionsmedicales.fr/mesh/D002518",
"about": {
"@type": "MedicalCondition",
"name": "Céramides",
"code": {
"@type": "MedicalCode",
"code": "D002518",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cérébrosides",
"alternateName": "Cerebrosides",
"url": "https://questionsmedicales.fr/mesh/D002554",
"about": {
"@type": "MedicalCondition",
"name": "Cérébrosides",
"code": {
"@type": "MedicalCode",
"code": "D002554",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Galactosylcéramides",
"alternateName": "Galactosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005699",
"about": {
"@type": "MedicalCondition",
"name": "Galactosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005699",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glucosylcéramides",
"alternateName": "Glucosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005963",
"about": {
"@type": "MedicalCondition",
"name": "Glucosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005963",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.490"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Galactosylcéramides",
"alternateName": "Galactosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005699",
"about": {
"@type": "MedicalCondition",
"name": "Galactosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005699",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glucosylcéramides",
"alternateName": "Glucosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005963",
"about": {
"@type": "MedicalCondition",
"name": "Glucosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005963",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.490"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Globosides",
"alternateName": "Globosides",
"url": "https://questionsmedicales.fr/mesh/D005915",
"about": {
"@type": "MedicalCondition",
"name": "Globosides",
"code": {
"@type": "MedicalCode",
"code": "D005915",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.425"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lactosylcéramides",
"alternateName": "Lactosylceramides",
"url": "https://questionsmedicales.fr/mesh/D007790",
"about": {
"@type": "MedicalCondition",
"name": "Lactosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D007790",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.612"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Trihexosylcéramide",
"alternateName": "Trihexosylceramides",
"url": "https://questionsmedicales.fr/mesh/D014281",
"about": {
"@type": "MedicalCondition",
"name": "Trihexosylcéramide",
"code": {
"@type": "MedicalCode",
"code": "D014281",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.906"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Cérébrosides",
"alternateName": "Cerebrosides",
"url": "https://questionsmedicales.fr/mesh/D002554",
"about": {
"@type": "MedicalCondition",
"name": "Cérébrosides",
"code": {
"@type": "MedicalCode",
"code": "D002554",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Galactosylcéramides",
"alternateName": "Galactosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005699",
"about": {
"@type": "MedicalCondition",
"name": "Galactosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005699",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glucosylcéramides",
"alternateName": "Glucosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005963",
"about": {
"@type": "MedicalCondition",
"name": "Glucosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005963",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.490"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Galactosylcéramides",
"alternateName": "Galactosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005699",
"about": {
"@type": "MedicalCondition",
"name": "Galactosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005699",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glucosylcéramides",
"alternateName": "Glucosylceramides",
"url": "https://questionsmedicales.fr/mesh/D005963",
"about": {
"@type": "MedicalCondition",
"name": "Glucosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D005963",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.250.490"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Globosides",
"alternateName": "Globosides",
"url": "https://questionsmedicales.fr/mesh/D005915",
"about": {
"@type": "MedicalCondition",
"name": "Globosides",
"code": {
"@type": "MedicalCode",
"code": "D005915",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.425"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lactosylcéramides",
"alternateName": "Lactosylceramides",
"url": "https://questionsmedicales.fr/mesh/D007790",
"about": {
"@type": "MedicalCondition",
"name": "Lactosylcéramides",
"code": {
"@type": "MedicalCode",
"code": "D007790",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.612"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Trihexosylcéramide",
"alternateName": "Trihexosylceramides",
"url": "https://questionsmedicales.fr/mesh/D014281",
"about": {
"@type": "MedicalCondition",
"name": "Trihexosylcéramide",
"code": {
"@type": "MedicalCode",
"code": "D014281",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.200.906"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sphingomyéline",
"alternateName": "Sphingomyelins",
"url": "https://questionsmedicales.fr/mesh/D013109",
"about": {
"@type": "MedicalCondition",
"name": "Sphingomyéline",
"code": {
"@type": "MedicalCode",
"code": "D013109",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.612.870"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Psychosine",
"alternateName": "Psychosine",
"url": "https://questionsmedicales.fr/mesh/D011609",
"about": {
"@type": "MedicalCondition",
"name": "Psychosine",
"code": {
"@type": "MedicalCode",
"code": "D011609",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.877.360.806"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Sphingolipides",
"alternateName": "Sphingolipids",
"code": {
"@type": "MedicalCode",
"code": "D013107",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Erich Gulbins",
"url": "https://questionsmedicales.fr/author/Erich%20Gulbins",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Biology, University of Duisburg-Essen, Essen, Germany."
}
},
{
"@type": "Person",
"name": "Giovanni D'Angelo",
"url": "https://questionsmedicales.fr/author/Giovanni%20D%27Angelo",
"affiliation": {
"@type": "Organization",
"name": "Interfaculty Institute of Bioengineering, Ecole polytechnique fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland giovanni.dangelo@epfl.ch Christopher.Clarke@stonybrookmedicine.edu lianacsilva@ff.ulisboa.pt."
}
},
{
"@type": "Person",
"name": "Anna Kovilakath",
"url": "https://questionsmedicales.fr/author/Anna%20Kovilakath",
"affiliation": {
"@type": "Organization",
"name": "Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA, United States."
}
},
{
"@type": "Person",
"name": "L Ashley Cowart",
"url": "https://questionsmedicales.fr/author/L%20Ashley%20Cowart",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, United States."
}
},
{
"@type": "Person",
"name": "Tyrone Dowdy",
"url": "https://questionsmedicales.fr/author/Tyrone%20Dowdy",
"affiliation": {
"@type": "Organization",
"name": "Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance.",
"datePublished": "2023-07-21",
"url": "https://questionsmedicales.fr/article/37548444",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3791/64785"
}
},
{
"@type": "ScholarlyArticle",
"name": "Real world clinical feasibility of direct-from-specimen antimicrobial susceptibility testing of clinical specimens with unknown microbial load or susceptibility.",
"datePublished": "2022-11-02",
"url": "https://questionsmedicales.fr/article/36323751",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-21970-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Antibiotic Sensitivity of",
"datePublished": "2022-12-21",
"url": "https://questionsmedicales.fr/article/36628152",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/7273627"
}
},
{
"@type": "ScholarlyArticle",
"name": "Microbial Biosynthesis of Chrysazin Derivatives in Recombinant",
"datePublished": "2022-08-29",
"url": "https://questionsmedicales.fr/article/36080320",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/molecules27175554"
}
},
{
"@type": "ScholarlyArticle",
"name": "Microbial Biofilms and Antibiofilm Agents 2.0.",
"datePublished": "2022-07-19",
"url": "https://questionsmedicales.fr/article/35887278",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms23147932"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Lipides",
"item": "https://questionsmedicales.fr/mesh/D008055"
},
{
"@type": "ListItem",
"position": 3,
"name": "Lipides membranaires",
"item": "https://questionsmedicales.fr/mesh/D008563"
},
{
"@type": "ListItem",
"position": 4,
"name": "Sphingolipides",
"item": "https://questionsmedicales.fr/mesh/D013107"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Sphingolipides - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Sphingolipides",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Sphingolipides",
"description": "Comment diagnostiquer une maladie liée aux sphingolipides ?\nQuels tests sont utilisés pour évaluer les sphingolipides ?\nLes symptômes peuvent-ils indiquer un déséquilibre des sphingolipides ?\nQuelle imagerie est utile pour les maladies des sphingolipides ?\nLes antécédents familiaux sont-ils importants pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Microbial+Sensitivity+Tests#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Sphingolipides",
"description": "Quels sont les symptômes des troubles liés aux sphingolipides ?\nLes troubles digestifs sont-ils associés aux sphingolipides ?\nComment les sphingolipides affectent-ils le système nerveux ?\nLes troubles de la peau sont-ils fréquents avec les sphingolipides ?\nLes symptômes varient-ils selon le type de sphingolipide ?",
"url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Microbial+Sensitivity+Tests#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Sphingolipides",
"description": "Peut-on prévenir les maladies liées aux sphingolipides ?\nLes tests génétiques aident-ils à la prévention ?\nL'éducation sur les sphingolipides est-elle importante ?\nLes habitudes alimentaires influencent-elles la santé des sphingolipides ?\nLes vaccinations peuvent-elles aider à prévenir des complications ?",
"url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Microbial+Sensitivity+Tests#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Sphingolipides",
"description": "Quels traitements existent pour les maladies des sphingolipides ?\nLa diète peut-elle influencer les niveaux de sphingolipides ?\nLes médicaments peuvent-ils réduire les symptômes ?\nY a-t-il des traitements expérimentaux pour ces maladies ?\nLa thérapie génique est-elle une option pour ces maladies ?",
"url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Microbial+Sensitivity+Tests#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Sphingolipides",
"description": "Quelles complications peuvent survenir avec les troubles des sphingolipides ?\nLes troubles respiratoires sont-ils une complication possible ?\nComment les sphingolipides affectent-ils le cœur ?\nLes complications neurologiques sont-elles fréquentes ?\nLes complications peuvent-elles être réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Microbial+Sensitivity+Tests#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Sphingolipides",
"description": "Quels sont les facteurs de risque pour les maladies des sphingolipides ?\nL'âge influence-t-il le risque de troubles des sphingolipides ?\nLes maladies auto-immunes sont-elles un facteur de risque ?\nLe mode de vie influence-t-il le risque ?\nLes infections peuvent-elles aggraver les troubles des sphingolipides ?",
"url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Microbial+Sensitivity+Tests#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une maladie liée aux sphingolipides ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests génétiques, des analyses biochimiques et des biopsies."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les sphingolipides ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des analyses d'urine mesurent les niveaux de sphingolipides."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils indiquer un déséquilibre des sphingolipides ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes neurologiques ou cutanés peuvent signaler un déséquilibre."
}
},
{
"@type": "Question",
"name": "Quelle imagerie est utile pour les maladies des sphingolipides ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM et la TDM peuvent aider à visualiser les effets des maladies sur les organes."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux sont-ils importants pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antécédents familiaux peuvent indiquer une prédisposition génétique aux maladies."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes des troubles liés aux sphingolipides ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des troubles neurologiques, des problèmes cutanés et des douleurs."
}
},
{
"@type": "Question",
"name": "Les troubles digestifs sont-ils associés aux sphingolipides ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains troubles digestifs peuvent être liés à des anomalies des sphingolipides."
}
},
{
"@type": "Question",
"name": "Comment les sphingolipides affectent-ils le système nerveux ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils jouent un rôle dans la myélinisation et la signalisation neuronale, affectant la fonction nerveuse."
}
},
{
"@type": "Question",
"name": "Les troubles de la peau sont-ils fréquents avec les sphingolipides ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des affections cutanées comme l'eczéma peuvent être liées à des déséquilibres."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de sphingolipide ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes dépendent du type de sphingolipide impliqué et de l'organe affecté."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les maladies liées aux sphingolipides ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un mode de vie sain peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Les tests génétiques aident-ils à la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier les personnes à risque et guider la prévention."
}
},
{
"@type": "Question",
"name": "L'éducation sur les sphingolipides est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, comprendre les sphingolipides aide à reconnaître les symptômes et à agir rapidement."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles la santé des sphingolipides ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée peut soutenir la santé des sphingolipides et prévenir des troubles."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles aider à prévenir des complications ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent prévenir des infections qui aggravent les troubles liés aux sphingolipides."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les maladies des sphingolipides ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des thérapies enzymatiques, des médicaments et des soins symptomatiques."
}
},
{
"@type": "Question",
"name": "La diète peut-elle influencer les niveaux de sphingolipides ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en acides gras essentiels peut aider à réguler les sphingolipides."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils réduire les symptômes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent atténuer les symptômes et améliorer la qualité de vie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux pour ces maladies ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des essais cliniques explorent de nouvelles thérapies pour les troubles des sphingolipides."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option pour ces maladies ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est en recherche pour traiter certaines maladies liées aux sphingolipides."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les troubles des sphingolipides ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles neurologiques graves, des infections et des défaillances organiques."
}
},
{
"@type": "Question",
"name": "Les troubles respiratoires sont-ils une complication possible ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains troubles des sphingolipides peuvent entraîner des complications respiratoires."
}
},
{
"@type": "Question",
"name": "Comment les sphingolipides affectent-ils le cœur ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des déséquilibres peuvent contribuer à des maladies cardiovasculaires et à des arythmies."
}
},
{
"@type": "Question",
"name": "Les complications neurologiques sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications comme la démence ou des troubles moteurs peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être irréversibles."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les maladies des sphingolipides ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des mutations génétiques et des déséquilibres nutritionnels."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de troubles des sphingolipides ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains troubles apparaissent plus fréquemment chez les enfants ou les personnes âgées."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies auto-immunes peuvent augmenter le risque de troubles liés aux sphingolipides."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles aggraver les troubles des sphingolipides ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections peuvent exacerber les symptômes et les complications."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 10/03/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Molecular Biology, University of Duisburg-Essen, Essen, Germany.
Department of Surgery, University of Cincinnati, Cincinnati, OH, United States.
Publications dans "Sphingolipides" :
3 publications dans cette catégorie
Affiliations :
Interfaculty Institute of Bioengineering, Ecole polytechnique fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland giovanni.dangelo@epfl.ch Christopher.Clarke@stonybrookmedicine.edu lianacsilva@ff.ulisboa.pt.
Publications dans "Sphingolipides" :
3 publications dans cette catégorie
Affiliations :
Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA, United States.
Publications dans "Sphingolipides" :
3 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, United States.
Richmond Veteran's Affairs Medical Center, Richmond, VA, United States.
Publications dans "Sphingolipides" :
3 publications dans cette catégorie
Affiliations :
Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
Publications dans "Sphingolipides" :
3 publications dans cette catégorie
Affiliations :
Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
Publications dans "Sphingolipides" :
2 publications dans cette catégorie
Affiliations :
Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Publications dans "Sphingolipides" :
2 publications dans cette catégorie
Affiliations :
Department of Toxicology, University of Potsdam, Nuthetal, Germany.
Publications dans "Sphingolipides" :
2 publications dans cette catégorie
Affiliations :
Department of Toxicology, University of Potsdam, Nuthetal, Germany.
Department of Molecular Biology, University of Duisburg-Essen, Essen, Germany.
Publications dans "Sphingolipides" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States.
Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX, United States.
Department of Neuroscience, Baylor College of Medicine, Houston, TX, United States.
Publications dans "Sphingolipides" :
2 publications dans cette catégorie
Affiliations :
Centre for Cancer Biology, University of South Australia and SA Pathology, UniSA CRI Building, North Tce, Adelaide, SA 5001, Australia; Adelaide Medical School, University of Adelaide, Adelaide, SA 5001, Australia; School of Biological Sciences, University of Adelaide, Adelaide, SA 5000, Australia. Electronic address: stuart.pitson@unisa.edu.au.
Publications dans "Sphingolipides" :
2 publications dans cette catégorie
Affiliations :
Institute of Neurogenetics, University of Luebeck, Ratzeburger Allee 160, 23562 Lübeck, Germany.
Publications dans "Sphingolipides" :
2 publications dans cette catégorie
Publications dans "Sphingolipides" :
2 publications dans cette catégorie
Publications dans "Sphingolipides" :
2 publications dans cette catégorie
Publications dans "Sphingolipides" :
2 publications dans cette catégorie
Affiliations :
Department of Ophthalmology, University of Tennessee Health Science Center, UTHSC, Memphis, TN, USA. nmandal@uthsc.edu.
Department of Anatomy and Neurobiology, University of Tennessee Health Science Center, UTHSC, Memphis, TN, USA. nmandal@uthsc.edu.
Publications dans "Sphingolipides" :
2 publications dans cette catégorie
Affiliations :
Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA, United States.
Department of Biochemistry and Molecular Biology, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, United States.
Publications dans "Sphingolipides" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Biology, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, United States.
Richmond Veteran's Affairs Medical Center, Richmond, VA, United States.
Publications dans "Sphingolipides" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry and Toxicology, Veterinary Research Institute, Hudcova 296/70, 62100 Brno, Czech Republic.
Publications dans "Sphingolipides" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry and Toxicology, Veterinary Research Institute, Hudcova 296/70, 62100 Brno, Czech Republic.
Publications dans "Sphingolipides" :
To improve the efficiency of antimicrobial susceptibility testing (AST) and phage high-throughput screening for resistant bacteria and to reduce the detection cost, an intelligent high-throughput AST/...
Within healthcare settings, physicians use antibiograms, which offer information on local susceptibility rates, as an aid in selecting empirical antibiotic therapy and avoiding the prescription of pot...
The study's objective was to determine...
Nonrepetitive...
A total of 317 patients were reviewed: 202 females (63.7%) and 115 males (36.3%)....
Highly effective antibiotics such as cefoxitin and ceftazidime should be used empirically by considering antibiotic sensitivity changes by sex, season, and year. Regional studies should be conducted f...
Anthraquinone and its derivatives show remarkable biological properties such as anticancer, antibacterial, antifungal, and antiviral activities. Hence, anthraquinones derivatives have been of prime in...
It is estimated that <0 [...]...
Gram-negative (GN) sepsis is a medical emergency where management in resource-limited settings relies on conventional microbiological culture techniques providing results in 3-4 days. Recognizing this...
Patients with myasthenia gravis (MG) are prone to the development of pneumonia due to the long-term immunotherapies they receive and a tendency for aspiration. Pneumonia remains a risk factor for MG w...
Between January 2013 and October 2022, we performed an inpatient database review for MG patients with pneumonia concurrence in a tertiary research center specializing in neuromuscular disorders. The c...
In our cohort, 90.32% (112/124) of organisms were bacteria and 42.86% (48/112) of pathogenic bacteria were carbapenem-resistant. A high abundance of Epstein-Barr virus (EBV) was detected using next-ge...
Our identification of the microbial etiology of pneumonia in MG patients may provide future perspectives on accurate antibiotic options and enable early interventions when risk factors are present....
Early diagnosis and treatment are important for a good prognosis of bloodstream infections. The European Committee on Antimicrobial Susceptibility Testing (EUCAST) recommends rapid antimicrobial susce...
Twenty strains of...
For...
EUCAST-RAST for...
Microbial keratitis (MK) is a significant cause of blindness in sub-Saharan Africa. We investigated the feasibility of using a novel corneal impression membrane (CIM) for obtaining and processing samp...
Samples were collected from patients presenting with suspected MK using a 12 mm diameter polytetrafluoroethylene CIM disc. Samples were processed using culture and PCR for...
71 eyes of 71 patients were included. The overall CIM isolation rate was 81.7% (58 positive samples from 71 participants). 69 (81.2%) of isolates were Gram-positive cocci. Coagulase-negative...
In a resource-poor setting, a CIM can be used to safely sample the cornea in patients presenting with suspected MK, enabling identification of causative microorganisms by culture and PCR. Although the...
Microbial persisters are defined as the tiny sub-population of microorganisms that develop intrinsic strategies for survival with high tolerance to various antimicrobials. Currently, persister researc...